Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Comparison of the patient and partner satisfaction with 700CX and Titan penile prostheses.

Otero JR, Cruz CR, Gómez BG, Geli JS, Polo JM, Castañé ER, Antolín AR.

Asian J Androl. 2017 May-Jun;19(3):321-325. doi: 10.4103/1008-682X.172822.

2.

Acquired hypermethylation of the P16INK4A promoter in abdominal paraganglioma: relation to adverse tumor phenotype and predisposing mutation.

Kiss NB, Muth A, Andreasson A, Juhlin CC, Geli J, Bäckdahl M, Höög A, Wängberg B, Nilsson O, Ahlman H, Larsson C.

Endocr Relat Cancer. 2013 Feb 18;20(1):65-78. doi: 10.1530/ERC-12-0267. Print 2013 Feb.

3.

Quantitative global and gene-specific promoter methylation in relation to biological properties of neuroblastomas.

Kiss NB, Kogner P, Johnsen JI, Martinsson T, Larsson C, Geli J.

BMC Med Genet. 2012 Sep 17;13:83. doi: 10.1186/1471-2350-13-83.

4.

Suppression of RIZ in biologically unfavourable neuroblastomas.

Geli J, Kiss N, Kogner P, Larsson C.

Int J Oncol. 2010 Nov;37(5):1323-30.

PMID:
20878080
5.

[Evaluation of the LightCycler 480 real-time PCR system for the measurement of CMV, EBV, HHV-6 and BKV viral loads in whole blood].

Boutolleau D, Deback C, Géli J, Aït-Arkoub Z, Angleraud F, Gautheret-Dejean A, Agut H.

Pathol Biol (Paris). 2010 Apr;58(2):166-9. doi: 10.1016/j.patbio.2009.06.006. Epub 2009 Nov 4. French.

PMID:
19892483
6.

Use of the Roche LightCycler 480 system in a routine laboratory setting for molecular diagnosis of opportunistic viral infections: Evaluation on whole blood specimens and proficiency panels.

Deback C, Géli J, Aït-Arkoub Z, Angleraud F, Gautheret-Dejean A, Agut H, Boutolleau D.

J Virol Methods. 2009 Aug;159(2):291-4. doi: 10.1016/j.jviromet.2009.03.027. Epub 2009 Apr 9.

PMID:
19490982
7.

Transcriptional profiling enables molecular classification of adrenocortical tumours.

Laurell C, Velázquez-Fernández D, Lindsten K, Juhlin C, Enberg U, Geli J, Höög A, Kjellman M, Lundeberg J, Hamberger B, Larsson C, Nilsson P, Bäckdahl M.

Eur J Endocrinol. 2009 Jul;161(1):141-52. doi: 10.1530/EJE-09-0068. Epub 2009 May 1.

8.

Gene-specific promoter hypermethylation without global hypomethylation in follicular thyroid cancer.

Lee JJ, Geli J, Larsson C, Wallin G, Karimi M, Zedenius J, Höög A, Foukakis T.

Int J Oncol. 2008 Oct;33(4):861-9.

PMID:
18813801
9.

Methylation of the p16INK4A promoter is associated with malignant behavior in abdominal extra-adrenal paragangliomas but not pheochromocytomas.

Kiss NB, Geli J, Lundberg F, Avci C, Velazquez-Fernandez D, Hashemi J, Weber G, Höög A, Ekström TJ, Bäckdahl M, Larsson C.

Endocr Relat Cancer. 2008 Jun;15(2):609-21. doi: 10.1677/ERC-07-0285.

10.

Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma.

Geli J, Kogner P, Lanner F, Natalishvili N, Juhlin C, Kiss N, Clark GJ, Ekström TJ, Farnebo F, Larsson C.

Int J Cancer. 2008 Jul 15;123(2):389-394. doi: 10.1002/ijc.23533.

11.

Global and regional CpG methylation in pheochromocytomas and abdominal paragangliomas: association to malignant behavior.

Geli J, Kiss N, Karimi M, Lee JJ, Bäckdahl M, Ekström TJ, Larsson C.

Clin Cancer Res. 2008 May 1;14(9):2551-9. doi: 10.1158/1078-0432.CCR-07-1867.

12.

The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma.

Geli J, Kiss N, Lanner F, Foukakis T, Natalishvili N, Larsson O, Kogner P, Höög A, Clark GJ, Ekström TJ, Bäckdahl M, Farnebo F, Larsson C.

Endocr Relat Cancer. 2007 Mar;14(1):125-34.

13.

Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy.

Velázquez-Fernández D, Laurell C, Geli J, Höög A, Odeberg J, Kjellman M, Lundeberg J, Hamberger B, Nilsson P, Bäckdahl M.

Surgery. 2005 Dec;138(6):1087-94.

PMID:
16360395
14.

The Ras effector NORE1A is suppressed in follicular thyroid carcinomas with a PAX8-PPARgamma fusion.

Foukakis T, Au AY, Wallin G, Geli J, Forsberg L, Clifton-Bligh R, Robinson BG, Lui WO, Zedenius J, Larsson C.

J Clin Endocrinol Metab. 2006 Mar;91(3):1143-9. Epub 2005 Dec 13.

PMID:
16352687
15.

Detailed assessment of chromosome 22 aberrations in sporadic pheochromocytoma using array-CGH.

Jarbo C, Buckley PG, Piotrowski A, Mantripragada KK, Benetkiewicz M, Diaz de Ståhl T, Langford CF, Gregory SG, Dralle H, Gimm O, Bäckdahl M, Geli J, Larsson C, Westin G, Akerström G, Dumanski JP.

Int J Cancer. 2006 Mar 1;118(5):1159-64.

16.

Deletions and altered expression of the RIZ1 tumour suppressor gene in 1p36 in pheochromocytomas and abdominal paragangliomas.

Geli J, Nord B, Frisk T, Edström Elder E, Ekström TJ, Carling T, Bäckdahl M, Larsson C.

Int J Oncol. 2005 May;26(5):1385-91.

PMID:
15809732
17.

Progesterone regulates IL12 expression in pregnancy lymphocytes by inhibiting phospholipase A2.

Par G, Geli J, Kozma N, Varga P, Szekeres-Bartho J.

Am J Reprod Immunol. 2003 Jan;49(1):1-5.

PMID:
12733588
18.

Artiodactyl IgD: the missing link.

Zhao Y, Kacskovics I, Pan Q, Liberles DA, Geli J, Davis SK, Rabbani H, Hammarstrom L.

J Immunol. 2002 Oct 15;169(8):4408-16.

Supplemental Content

Support Center